Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396613 · ClinicalTrials.gov registry record · NA
Wound Closure Techniques in Primary Spine Surgery
A NA study of Spinal Injuries, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 147
- Enrollment target
- 1
- Study location
NCT04396613: Recruiting NA study of Spinal Injuries, sponsored by Mayo Clinic.
NCT04396613 is a NA study of Spinal Injuries that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 147 participants, roughly in line with the 162-participant average among 3 other Spinal Injuries trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04396613, a NA study of Spinal Injuries, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
The Researchers are trying to determine if there is a difference in blood flow around a wound site when comparing three different types of wound closure techniques.
Primary Outcome
Lowest perfusion score per 10 measurements taken along the wound closure as a percentage of perfusion at a standard location (5cm above incision).
Conditions Studied
Interventions
- PROCEDURE Closure technique
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT04396613 shows while recruiting
NCT04396613 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 162-participant average among 3 other Spinal Injuries trials with a reported enrollment target.
The record links to 1 condition, with Spinal Injuries appearing as the primary indexed condition, and to 1 intervention - of which Closure technique is the first listed.
NCT04396613 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04396613 about?
NCT04396613 is a clinical study titled "Wound Closure Techniques in Primary Spine Surgery". The Researchers are trying to determine if there is a difference in blood flow around a wound site when comparing three different types of wound closure techniques.
What is the current status of trial NCT04396613?
This trial is currently recruiting. It is a NA study. The enrollment target is 147 participants. The study started on 2019-04-01. Estimated completion is 2026-03.
What conditions does trial NCT04396613 study?
This clinical trial studies the following conditions: Spinal Injuries.
What interventions are being tested in trial NCT04396613?
The interventions under investigation include: Closure technique (PROCEDURE).
Who is sponsoring clinical trial NCT04396613?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04396613 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06184516 · 147 participants · Phase 2
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI